Regrow Biosciences Overview
- Year Founded
-
1989

- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.34M
Regrow Biosciences General Information
Description
Operator of a biotechnology company intended to improve human healthcare by innovating and delivering regenerative medicine-based healthcare services. The company's services mainly focus on the regeneration of tissue through cell therapy that involves introducing healthy cells into a diseased tissue to trigger the body's ability to heal itself, purification of cells to retain a single type of cell, implantation of cultured cells, enabling patients to have access to innovative cell therapy in orthopedic products and rebuild their lives by regenerating cells.
Contact Information
Website
www.regrow.inCorporate Office
- 2 ABC, ACME Plaza Andheri Kurla Road
- Near Chakala Metro Station, Andheri East
- Mumbai, Maharshtra 400059
- India
Corporate Office
- 2 ABC, ACME Plaza Andheri Kurla Road
- Near Chakala Metro Station, Andheri East
- Mumbai, Maharshtra 400059
- India
Regrow Biosciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Later Stage VC | 21-Sep-2019 | $1.34M | Completed | Generating Revenue | ||
2. Later Stage VC | 24-May-2017 | Completed | Generating Revenue | |||
1. Later Stage VC | 12-Oct-2014 | $321K | $321K | Completed | Generating Revenue |
Regrow Biosciences Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | 76,350 | $0.139384 | $0.93 | $0.93 | 1x | $0.93 | 3.25% | |
Ordinary | 223,076 | $0.139384 | $0.91 | $0.91 | 1x | $0.91 | 9.49% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Regrow Biosciences Patents
Regrow Biosciences Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240287458-A1 | Method of obtaining hsc population, t cell population and nk cell population and compositions thereof | Pending | 30-Jun-2021 | ||
US-20220098553-A1 | Method for mesenchymal stem cell isolation and osteoblast differentiation | Pending | 08-Feb-2019 | ||
US-20220096562-A1 | Osteoblast cell-mixture, and implementations thereof | Inactive | 08-Feb-2019 | ||
US-20220184132-A1 | Platelet lysate, and method of preparation thereof | Active | 08-Feb-2019 | ||
US-12097221-B2 | Platelet lysate, and method of preparation thereof | Active | 08-Feb-2019 | A61K35/19 |
Regrow Biosciences FAQs
-
When was Regrow Biosciences founded?
Regrow Biosciences was founded in 1989.
-
Where is Regrow Biosciences headquartered?
Regrow Biosciences is headquartered in Mumbai, India.
-
What industry is Regrow Biosciences in?
Regrow Biosciences’s primary industry is Biotechnology.
-
Is Regrow Biosciences a private or public company?
Regrow Biosciences is a Private company.
-
What is the current valuation of Regrow Biosciences?
The current valuation of Regrow Biosciences is
. -
What is Regrow Biosciences’s current revenue?
The current revenue for Regrow Biosciences is
. -
How much funding has Regrow Biosciences raised over time?
Regrow Biosciences has raised $1.8M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »